Cargando...
Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab
We report two patients with normocomplementaemic urticarial vasculitis with impressive response to omalizumab. This contrasts recent reports on hypocomplementaemic urticarial vasculitis syndrome, highlighting the need for clinical trials of omalizumab in normocomplementaemic urticarial vasculitis.
Gardado en:
| Publicado en: | Clin Transl Allergy |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6149008/ https://ncbi.nlm.nih.gov/pubmed/30258566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-018-0222-y |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|